Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Airway surface liquid concentrations of aztreonam lysine for inhalation in children with cystic fibrosis: A modeling study

Cedric Van Holsbeke, Aukje Bos, Wim Vos, Jan De Backer, Hettie Janssens, Harm Tiddens
European Respiratory Journal 2013 42: P2114; DOI:
Cedric Van Holsbeke
1Respiratory, FluidDA Nv, Kontich, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aukje Bos
2Department of Pediatric Pulmonology and Allergology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim Vos
1Respiratory, FluidDA Nv, Kontich, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan De Backer
1Respiratory, FluidDA Nv, Kontich, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hettie Janssens
2Department of Pediatric Pulmonology and Allergology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harm Tiddens
2Department of Pediatric Pulmonology and Allergology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, Netherlands
3Department of Pediatric Radiology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Introduction

The mechanics of inhaled antibiotics in obstructed airways are not well known. It is possible that local areas with concentration below the minimal inhibitory concentration (10xMIC90, 128µg/ml for P. Aeruginosa) exist, causing undertreated parts of the lung. To optimize inhaled therapy, knowledge about antibiotic concentrations throughout the lung should be known. Local deposition characteristics of inhaled Aztreonam lysine (AZLI) were simulated using Functional Respiratory Imaging.

Methods

Airways and lungs were segmented from a retrospective dataset of 40 in- and expiratory CT-scans of children with cystic fibrosis (CF) between 5 and 17 years. FRI simulations were performed that simulated the nebulisation of 75mg AZLI through PARI eFlow® with minimal/median/maximal reported aerodynamic diameters (MMAD) and different thicknesses of airway surface liquid (ASL). Figure 1 shows local concentrations in the central airways and lung.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Results

In Figure 2, it is shown how many lobes are being undertreated.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Conclusion

Parts of the CF-lung receive concentrations < 10xMIC90 with inhaled antibiotics, such as AZLI.

  • Imaging
  • Bacteria
  • © 2013 ERS
Previous
Back to top
Vol 42 Issue Suppl 57 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Airway surface liquid concentrations of aztreonam lysine for inhalation in children with cystic fibrosis: A modeling study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Airway surface liquid concentrations of aztreonam lysine for inhalation in children with cystic fibrosis: A modeling study
Cedric Van Holsbeke, Aukje Bos, Wim Vos, Jan De Backer, Hettie Janssens, Harm Tiddens
European Respiratory Journal Sep 2013, 42 (Suppl 57) P2114;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Airway surface liquid concentrations of aztreonam lysine for inhalation in children with cystic fibrosis: A modeling study
Cedric Van Holsbeke, Aukje Bos, Wim Vos, Jan De Backer, Hettie Janssens, Harm Tiddens
European Respiratory Journal Sep 2013, 42 (Suppl 57) P2114;
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Human neutrophils release bioactive inflammasome complexes; relevance for cystic fibrosis
  • Efficacy and safety of inhaled antibiotics for chronic pseudomonas infection in cystic fibrosis: Network meta-analysis
  • Infant lung function testing: First in vivo report of a novel inert gas washout method to measure LCI
Show more 7.3 Cystic Fibrosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society